In IgG4-RD, the expansion of CD20+ B cells and plasmablasts, as well as antigen presentation to CD4+ cytotoxic T cells, have been implicated in disease pathogenesis (26–28). This evidence concerns the gene CD4 and immunoglobulin G4-related sclerosing disease.